SCOPODERM

This brand name is authorized in Estonia, Finland, France, Netherlands, New Zealand, Singapore, South Africa, UK.

Active ingredients

The drug SCOPODERM contains one active pharmaceutical ingredient (API):

1	Scopolamine UNII DL48G20X8X - SCOPOLAMINE
	Scopolamine is a naturally occurring belladonna alkaloid and has anticholinergic properties. It acts as a competitive antagonist to acetylchloline and other parasympathomimetic agents. Its mechanism of action in the central nervous system in preventing motion sickness has yet to be elucidated. Scopolamine produces classical symptoms of parasympathetic blockade.
	Read more about Scopolamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SCOPODERM Transdermal patch	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A04AD01	Scopolamine	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1172483
FI	Lääkealan turvallisuus- ja kehittämiskeskus	062463, 396250
FR	Base de données publique des médicaments	63034382, 63958849
GB	Medicines & Healthcare Products Regulatory Agency	377281, 92446
NL	Z-Index G-Standaard, PRK	18082
NZ	Medicines and Medical Devices Safety Authority	3625
SG	Health Sciences Authority	03114P
ZA	Health Products Regulatory Authority	R/5.7.2/161